Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc., a Golden Valley, Minnesota–based manufacturer of FDA-approved implantable neurostimulation devices, operates as a prime contractor supplying sleep apnea treatment hardware and related components to federal healthcare agencies. The company is self-certified as a small disadvantaged business and competes predominantly under full-and-open procurements across the GSA Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A), with no set-aside designations across its federal portfolio.

Inspire's core federal capability centers on the INSPIRE Sleep Apnea System—an implantable upper airway stimulation device providing mask-free treatment for moderate to severe obstructive sleep apnea—and its component parts: implantable pulse generators, stimulation leads, respiratory sensing leads, and sleep remote controls. Representative work includes a $50,150.76 delivery order from Veterans Integrated Service Network 16 (June 2026) for complete INSPIRE Therapy implant components, a $100,502.53 delivery order from VISN 2 (April 2026) for complete INSPIRE Medical Devices, and a $142,010.04 purchase order from VISN 2 (July 2025) for bulk implants. The company also maintains a $2 million blanket purchase agreement with the Defense Health Agency running through February 2026 for implantable upper airway stimulation devices and related consumables supporting military healthcare beneficiaries.

Customer concentration is heavily weighted to the Veterans Affairs healthcare system. The top five customers by award count account for 68 percent of recent awards, dominated by Veterans Integrated Service Network 10 (452 awards, $10.9 million combined potential value), VISN 16 (132 awards, $3.3 million), and VISN 12 (111 awards, $107.3 million). Across potential value, the ranking shifts: VISN 12 anchors 75 percent of total federal dollars at $107.3 million across 111 awards, reflecting large standing delivery orders and bulk procurements, while VISN 10 places 452 individual smaller task orders averaging $24,000 per award. The Defense Health Agency ranks third by dollar value ($5.1 million across 49 awards), followed by the Army Medical Command ($2.3 million across 14 awards). Inspire has worked with 25 distinct federal agencies in the source dataset, but VA VISNs represent the dominant customer base.

Inspire holds a single parent vehicle: the GSA Medical Equipment and Supplies Federal Supply Schedule (FSS-65-II-A), under which 905 task orders have been placed carrying $29.2 million in combined potential value. This is a blanket supply schedule rather than a dedicated IDIQ, enabling streamlined ordering across multiple VA regional networks and the Defense Health Agency without competitive re-solicitation at the task-order level.

Activity has remained stable over the past five years—ranging from 83 to 199 awards per year—with 2022 showing peak volume at 199 awards, declining to 82 awards year-to-date in 2026. Twenty-nine awards valued at $2.1 million combined potential reach ultimate completion within the next twenty-four months, representing modest recompete exposure relative to the $143.1 million total federal portfolio. The company invoiced approximately $35.5 million (25 percent obligated of ceiling value) across all awards, indicating steady utilization of its GSA schedule ceiling capacity.

Inspire holds no identified subcontractor relationships in the source data; all 1,251 awards are prime contracts. The company's federal footprint is entirely within medical device manufacturing and supply—1,023 awards under NAICS 334517 (Electromedical and Electrotherapeutic Apparatus Manufacturing), 167 under surgical appliance manufacturing, and 58 under surgical instrument manufacturing. PSC coding reflects medical and surgical instruments and equipment (1,229 awards) alongside hospital equipment and supplies.